MARIA PLATA: Open Payments
NPI 1679220677 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,887 in 174 payments from 23 companies in 2025. Trend: 2023 $2,693 · 2024 $3,997 · 2025 $4,887
Food & beverage: $4,887
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $1,105 |
| Janssen Biotech, Inc. | 17 | $702 |
| Lilly USA, LLC | 13 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $332 |
| Janssen Scientific Affairs, LLC | 4 | $313 |
| Aimmune Therapeutics, Inc. | 10 | $264 |
| Novo Nordisk Inc | 3 | $213 |
| Regeneron Healthcare Solutions, Inc. | 8 | $199 |
| Gilead Sciences, Inc. | 5 | $198 |
| Ipsen Biopharmaceuticals, Inc | 5 | $188 |
Products named: TREMFYA, RINVOQ, ZENPEP, ENTYVIO, LINZESS, DUPIXENT, CREON, Wegovy.
Industry payments across AR — which companies pay providers there.
